Literature DB >> 35598227

Microvascular changes in the recurrent cystoid macular edema secondary to posterior noninfectious uveitis on optical coherence tomography angiography.

Valeria Albano1, Silvana Guerriero1, Claudio Furino1, Giancarlo Sborgia1, Alessandra Sborgia1, Rosanna Dammacco1, Francesco Boscia1, Giovanni Alessio2.   

Abstract

BACKGROUND: Posterior uveitis represents the second most frequent type of uveitis (15-30% of all uveitis). Noninfectious posterior uveitis complicated with secondary cystoid macular edema (CME) affects the visual prognosis negatively. The objective of the current study is to detect possible microvascular changes causing relapsing uveitis-related CME using optical coherence tomography angiography (OCTA).
METHODS: This is an interventional, observational, retrospective study with 1 year follow-up. Patients with noninfectious, posterior uveitis-related CME undergoing dexamethasone (DEX) implant were evaluated. Following the DEX-implant were carried out control visits after 1 month, 2-months, 4-months, 6-months, and for up 1-year. A total of 76 eyes of 38 consecutive patients with noninfectious posterior uveitis were enrolled (consecutive sample). Complicated noninfectious posterior uveitis with secondary CME was diagnosed in 56 eyes of uveitis patients (73.7%) and reviewed.
RESULTS: Our investigation showed (1) a reduction in superficial vessel plexus (SVP) measurements within 2-month (84%), reaching 96.4% for up 1-year, (2) an irregular profile of SVP in 69.6% of cases, persisting for up 1-year; relapsing uveitis-related CME eyes with irregular superficial foveal avascular zone (FAZ) profile were in 51%, while the SVP measurements reestablished in 100% of cases. Conversely, (3) the deep vascular plexus (DVP) parameters restored in a lower number of eyes within the 2-month (39.3%), remaining abnormal in 46.4% of cases for up 1-year; despite DVP restored in 53.6% of cases for up 1 year, (4) a capillary rarefaction ring around the FAZ appeared in 80.4% of cases; the relapsing uveitis-related CME eyes with abnormal DVP parameters were present in 41% of cases, of which 92.1% showed a rarefaction ring had abnormal DVP.
CONCLUSIONS: The use of OCTA enabled the evaluation in detail of retinal microvascular changes. We suggested that the possibility of the recurrence of the uveitis-related CME depends on the persistence of modifications of the superficial and deep layers. In this regard, we propose to implement the current imaging armamentarium with OCTA for the follow-up of patients with noninfectious uveitis-related CME.
© 2022. The Author(s).

Entities:  

Keywords:  Cystoid macular edema; Non-infectious posterior uveitis; Optical coherence tomography angiography

Year:  2022        PMID: 35598227     DOI: 10.1007/s10792-022-02327-0

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.029


  62 in total

1.  Adrenal function after prolonged corticosteroid therapy.

Authors:  B H ROBINSON; D MATTINGLY; C L COPE
Journal:  Br Med J       Date:  1962-06-09

2.  OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN PATIENTS WITH BEHÇET UVEITIS.

Authors:  Moncef Khairallah; Nesrine Abroug; Sana Khochtali; Anis Mahmoud; Bechir Jelliti; Gabriel Coscas; Marco Lupidi; Rim Kahloun; Salim Ben Yahia
Journal:  Retina       Date:  2017-09       Impact factor: 4.256

Review 3.  Cystoid macular oedema in uveitis: an unsolved problem.

Authors:  G Freeman; K Matos; C E Pavesio
Journal:  Eye (Lond)       Date:  2001-02       Impact factor: 3.775

Review 4.  Insights into the pathogenesis of cystoid macular edema: leukostasis and related cytokines.

Authors:  Yoo-Ri Chung; Young Ho Kim; Seung Yeop Lee; Hye-Eun Byeon; Kihwang Lee
Journal:  Int J Ophthalmol       Date:  2019-07-18       Impact factor: 1.779

Review 5.  Pathomechanisms of cystoid macular edema.

Authors:  Andreas Bringmann; Andreas Reichenbach; Peter Wiedemann
Journal:  Ophthalmic Res       Date:  2004 Sep-Oct       Impact factor: 2.892

6.  Intravitreal Dexamethasone Implant for the Treatment of Macular Edema in Chronic Non-infectious Uveitis.

Authors:  Adrian C Tsang; Gianni Virgili; Maryam Abtahi; Chloe C Gottlieb
Journal:  Ocul Immunol Inflamm       Date:  2016-05-18       Impact factor: 3.070

Review 7.  Local (topical and intraocular) therapy for ocular Adamantiades-Behçet's disease.

Authors:  Claudia Fabiani; Jorge L Alió
Journal:  Curr Opin Ophthalmol       Date:  2015-11       Impact factor: 3.761

8.  STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration.

Authors:  Jérémie F Cohen; Daniël A Korevaar; Douglas G Altman; David E Bruns; Constantine A Gatsonis; Lotty Hooft; Les Irwig; Deborah Levine; Johannes B Reitsma; Henrica C W de Vet; Patrick M M Bossuyt
Journal:  BMJ Open       Date:  2016-11-14       Impact factor: 2.692

9.  Intravitreal Dexamethasone Implant in the Treatment of Non-infectious Uveitis

Authors:  Murat Hasanreisoğlu; Hüseyin Baran Özdemir; Kaan Özkan; Murat Yüksel; Zeynep Aktaş; Hatice Tuba Atalay; Şengül Özdek; Gökhan Gürelik
Journal:  Turk J Ophthalmol       Date:  2019-10-24

10.  Comparison of two techniques used in routine care for the treatment of inflammatory macular oedema, subconjunctival triamcinolone injection and intravitreal dexamethasone implant: medical and economic importance of this randomized controlled trial.

Authors:  Chloé Couret; Alexandra Poinas; Christelle Volteau; Valery-Pierre Riche; Marie-Laure Le Lez; Marie-Hélène Errera; Catherine Creuzot-Garcher; Stéphanie Baillif; Laurent Kodjikian; Catherine Ivan; Laurence Mathilde Le Jumeau de Kergaradec; Anne Chiffoleau; Alexandra Jobert; Julie Jaulin; Laetitia Biron; Elisabeth Hervouet; Michel Weber
Journal:  Trials       Date:  2020-02-10       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.